Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in Morbidly Obese Patients
NCT01855217Phase 3Unknown
- Start
- Apr 2013
- Primary completion
- Apr 2014
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Sugammadex in neuromuscular blockade (NMB). Status: unknown.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01855217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01855217.